For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Scope of the Report:
In the last several years, global market of Equine Pharmaceuticals and Supplements developed rapidly, with an average growth rate of 4.52% during 2013 to 2017. In 2017, global revenue of Equine Pharmaceuticals and Supplements is nearly 977 M USD; the actual production is about 13700 K Unit.
Market competition is not intense. Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The worldwide market for Equine Pharmaceuticals and Supplements is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 1250 million US$ in 2024, from 1020 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Equine Pharmaceuticals and Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Boehringer Ingelheim
- Merck Animal Health
- Zoetis
- Bayer Animal Health
- Elanco Animal Health
- Dechra Veterinary Products
- CEVA
- Virbac
- Norbrook Equine
- Kyoritsu Seiyaku
- Vetoquinol
- Protexin Healthcare
- Audevard
- Ouro Fino Saude
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Pharmaceuticals
- Supplements
Market Segment by Applications, can be divided into
- Thoroughbred Horse
- Other Types of Horses
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Equine Pharmaceuticals and Supplements product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Equine Pharmaceuticals and Supplements, with price, sales, revenue and global market share of Equine Pharmaceuticals and Supplements in 2017 and 2018.
Chapter 3, the Equine Pharmaceuticals and Supplements competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Equine Pharmaceuticals and Supplements breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, customers, research findings and conclusion, appendix and data source.